Materialise NV to Report Fourth Quarter 2015 Earnings on Wednesday, March 2, 2016
Feb 09, 2016 13:30 pm UTC| Business
LEUVEN, Belgium, Feb. 09, 2016 -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for...
Michelle Williams Premieres Exclusive Home Collection During EVINE Live’s 1st Birthday Bash
Feb 09, 2016 13:30 pm UTC| Business
MINNEAPOLIS, Feb. 09, 2016 -- EVINE Live (NASDAQ:EVLV), a digital commerce company (evine.com), will debut the full line of “Believe by Michelle Williams,” an exclusive collection of products from Grammy award winning...
OmniComm Systems® to Present EHR to EDC eSource Strategies at eClinical Forum Webinar
Feb 09, 2016 13:15 pm UTC| Business
FORT LAUDERDALE, Fla., Feb. 09, 2016 -- OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global provider of clinical data capture technology, announced that it will present at the eClinical Forum “Birds of a Feather”...
Feb 09, 2016 13:10 pm UTC| Business
DUBLIN, Feb. 09, 2016 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced...
Feb 09, 2016 13:03 pm UTC| Business
WARREN, N.J., Feb. 09, 2016 -- Bellerophon Therapeutics,Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive data from the final analysis of the Company’s Phase 2 long-term extension...
RedHill Biopharma Issues Letter to Shareholders
Feb 09, 2016 13:00 pm UTC| Business
TEL-AVIV, Israel, Feb. 09, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), an Israeli biopharmaceutical company primarily focused on the development and commercialization of late...
Ultragenyx to Present at the Leerink Partners Annual Healthcare Conference
Feb 09, 2016 13:00 pm UTC| Business
NOVATO, Calif., Feb. 09, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Shalini...